» Articles » PMID: 18357393

Prevalence of BER Gene Polymorphisms in Sporadic Breast Cancer

Overview
Journal Oncol Rep
Specialty Oncology
Date 2008 Mar 22
PMID 18357393
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Studies suggest that breast cancer is initiated by the induction of somatic mutations from errors in the base excision repair (BER) of endogenous estrogen-induced abasic sites. If so, the inheritance of certain polymorphic mutations in BER genes involved in the incorporation and management of such errors should increase the risk of breast cancer. To test this hypothesis, we examined breast tissues from 48 women (controls, histopathologically normal tissue from reduction mammoplasty) and 40 women with breast cancer (breast tumor-adjacent, histopathologically normal tissues) for the presence of reported polymorphic mutations in four BER genes. The breast tissues were obtained from the Cooperative Human Tissue Network-western division and from the University of Nebraska Medical Center. Using PCR-RFLP procedures, the XRCC1 gene was examined for Arg194Trp and Arg399Gln, APE1 for Asp148Glu, LIG3alpha for Arg780His and PARP1 for Pro377Ser mutations. The women in this study carried only the XRCC1 Arg399Gln polymorphism. This result was surprising because APE1 148Glu was reported to be frequently inherited (allele frequency, 0.47-0.495) by USA and European women. Thus, the USA women in our study are genetically different from those in the previous studies. Among the control women, 21 (43.75%) were Arg/Arg wild-types, 20 (41.67%) were Arg/Gln heterozygotes and 7 (14.6%) were Gln/Gln homozygotes. Among the breast cancer cases, 11 (27.5%) were Arg/Arg wild-types, 16 (40%) were Arg/Gln heterozygotes and 13 (32.5%) were Gln/Gln homozygotes. Thus, the Gln allele was significantly more frequent in breast cancer cases (allele frequency, 0.52) than in controls (allele frequency, 0.35), suggesting that XRCC1 399Gln may enhance the risk of breast cancer.

Citing Articles

Polymorphisms in BER genes and risk of breast cancer: evidences from 69 studies with 33760 cases and 33252 controls.

Qiao L, Feng X, Wang G, Zhou B, Yang Y, Li M Oncotarget. 2018; 9(22):16220-16233.

PMID: 29662639 PMC: 5882330. DOI: 10.18632/oncotarget.23804.


Modulation of trinucleotide repeat instability by DNA polymerase β polymorphic variant R137Q.

Ren Y, Lai Y, Laverde E, Lei R, Rein H, Liu Y PLoS One. 2017; 12(5):e0177299.

PMID: 28475635 PMC: 5419657. DOI: 10.1371/journal.pone.0177299.


XRCC1 and OGG1 Gene Polymorphisms and Breast Cancer: A Systematic Review of Literature.

Moghaddam A, Nazarzadeh M, Noroozi R, Darvish H, Mosavi Jarrahi A Iran J Cancer Prev. 2016; 9(1):e3467.

PMID: 27366307 PMC: 4922200. DOI: 10.17795/ijcp-3467.


Efficiency of Base Excision Repair of Oxidative DNA Damage and Its Impact on the Risk of Colorectal Cancer in the Polish Population.

Kabzinski J, Mucha B, Cuchra M, Markiewicz L, Przybylowska K, Dziki A Oxid Med Cell Longev. 2015; 2016:3125989.

PMID: 26649135 PMC: 4663340. DOI: 10.1155/2016/3125989.


Polymorphisms of the XRCC1 gene and breast cancer risk in the Mexican population.

Macias-Gomez N, Peralta-Leal V, Meza-Espinoza J, Gutierrez-Angulo M, Duran-Gonzalez J, Ramirez-Gonzalez J Fam Cancer. 2015; 14(3):349-54.

PMID: 25690738 DOI: 10.1007/s10689-015-9787-y.